COVID-19 Clinical Development Advancements in Southeast Asia
Clinical trials are a critical phase in the development of any new medicine. They are vital to determining the impact the treatment may have on patients. Since the beginning of the COVID-19 pandemic, clinical researchers throughout Southeast Asia have been working rapidly to test investigational medicines and identify possible vaccine candidates that may treat patients and prevent further spread of the virus.
What They Are Saying: IP Protections Critical to Combatting COVID-19 in Southeast Asia
The global biopharmaceutical industry relies on strong intellectual property (IP) rights to promote the development of breakthrough treatments and cures for patients. Innovation, underpinned by reliable IP protections, is now more important than ever as the private sector works around the clock to develop solutions to help prevent infection and treat patients with COVID-19.
World Health Assembly: Intellectual Property in the SEA Region
The World Health Assembly (WHA) is being held virtually this week, including delegations from 194 World Health Organization member states. These officials will discuss the world’s response to the COVID-19 pandemic and determine the priorities of the Organization for the year ahead.
World Bank, IMF step up support for Southeast Asia’s health systems
Health systems in many low- and middle-income countries across Asia, the Middle East, Africa and Latin America are strained as they cope with the COVID-19 pandemic. Many nations lack the medical staff, equipment and capacities necessary to mitigate the crisis. While governments and corporations are partnering to strengthen health systems, multinational organizations are also stepping in with financial support.